Roberta Turiello

Fisciano, 84084, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Longitudinal spatial neutrophil profiling during ACT in murine melanoma reveals distinct lymph node infiltration patterns.

Longitudinal spatial neutrophil profiling during ACT in murine melanoma reveals distinct lymph node infiltration patterns.

Journal: NPJ systems biology and applications

Published: February 25, 2026

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.

Journal: Nature communications

Published: May 01, 2025

NKG7 is a Stable Marker of Cytotoxicity Across Immune Contexts and Within the Tumor Microenvironment.

NKG7 is a Stable Marker of Cytotoxicity Across Immune Contexts and Within the Tumor Microenvironment.

Journal: European journal of immunology

Published: February 15, 2025

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.

Journal: Nature communications

Published: September 29, 2023

The CD73 is induced by TGF-β1 triggered by nutrient deprivation and highly expressed in dedifferentiated human melanoma.

The CD73 is induced by TGF-β1 triggered by nutrient deprivation and highly expressed in dedifferentiated human melanoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 15, 2023

Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma.

Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma.

Journal: Journal for immunotherapy of cancer

Published: March 14, 2023

Lack of Ecto-5'-Nucleotidase Protects Sensitized Mice against Allergen Challenge.

Lack of Ecto-5'-Nucleotidase Protects Sensitized Mice against Allergen Challenge.

Journal: Biomolecules

Published: March 31, 2022

A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice.

A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice.

Journal: Frontiers in cell and developmental biology

Published: February 15, 2022

Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents.

Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents.

Journal: Journal for immunotherapy of cancer

Published: February 08, 2022

Thrombo-Inflammation: A Focus on NTPDase1/CD39.

Thrombo-Inflammation: A Focus on NTPDase1/CD39.

Journal: Cells

Published: July 29, 2021

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.

Journal: Journal for immunotherapy of cancer

Published: November 27, 2020

Adenosine Signaling in the Tumor Microenvironment.

Adenosine Signaling in the Tumor Microenvironment.

Journal: Advances in experimental medicine and biology

Published: October 30, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026